Events
Few drugs in history have generated as much controversy as MDMA and held as much promise. Once vilified as a Schedule I substance that would supposedly eat holes in users’ brains, MDMA (also known as Molly or Ecstasy) is now being hailed as a therapeutic agent that could transform the field of mental health and outpace competitors as the first psychedelic approved for widespread clinical use. From cutting-edge labs to pulsing club floors, science journalist Rachel Nuwer guides readers through a cultural and scientific upheaval that is rewriting our understanding of our brains, our selves, and the space between.
Rachel Nuwer is an award-winning science journalist who regularly contributes to the New York Times, National Geographic, and Scientific American. Her reporting for the New York Times broke the news globally about the MDMA Phase III clinical trial. Her first book is Poached: Inside the Dark World of Wildlife Trafficking.